Antitumor Effect of the Tyrosine Kinase Inhibitor Nilotinib on Gastrointestinal Stromal Tumor (GIST) and Imatinib-Resistant GIST Cells-Reference-Cited by-同舟云学术

Antitumor Effect of the Tyrosine Kinase Inhibitor Nilotinib on Gastrointestinal Stromal Tumor (GIST) and Imatinib-Resistant GIST Cells

Published:2014-09-15 Issue:9 Volume:9 Page:e107613
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Sako Hiroyuki,Fukuda Kazumasa,Saikawa Yoshiro,Nakamura Rieko,Takahashi Tsunehiro,Wada Norihito,Kawakubo Hirohumi,Takeuchi Hiroya,Ohmori Tai,Kitagawa Yuko

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference42 articles.

1. Gastrointestinal stromal tumours: Origin and molecular oncology;CL Corless;Nat Rev Cancer,2011

2. Gastrointestinal pacemaker cell tumor (GIPACT): Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal;LG Kindblom;Am J Pathol,1998

3. Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor;S Yuzawa;Cell,2007

4. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors;S Hirota;Science 279,1998

5. Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033;CD Blanke;J Clin Oncol 26,2008

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advance of clinically approved small-molecule drugs for the treatment of myeloid leukemia;European Journal of Medicinal Chemistry;2023-12

2. SEMCM: A Self-Expressive Matrix Completion Model for Anti-cancer Drug Sensitivity Prediction;Current Bioinformatics;2022-06

3. Association of Dasatinib With Progression-Free Survival Among Patients With Advanced Gastrointestinal Stromal Tumors Resistant to Imatinib;JAMA Oncology;2018-06-01

4. Expression and phosphorylation of FOXO1 influences cell proliferation and apoptosis in the gastrointestinal stromal tumor cell line GIST-T1;Experimental and Therapeutic Medicine;2018-02-08

5. Anti-tumor efficacy of oncolytic reovirus against gastrointestinal stromal tumor cells;Oncotarget;2017-12-18